Kwon et al. studied 180 patients with resected ESCC and found FGFR1 amplification in 21.4% (37/173) patients; they observed that FGFR1 amplification was an independent predictor of prolonged OS in these patients [14]. Here, FGFR1 is linked to esophageal squamous cell carcinoma.